Barclays »

Bioxcel Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 88 0.00
2024-06-30 $0 137 0.00
2024-03-31 $41k 15k 2.79
2023-12-31 $82k 28k 2.95
2023-09-30 $18k 7.7k 2.41
2023-06-30 $671k 101k 6.66
2023-03-31 $1.0M 56k 18.65
2022-12-31 $111k 5.1k 21.61
2022-09-30 $10k 811 12.33
2022-06-30 $33k 2.4k 13.53
2022-03-31 $61k 2.9k 21.11
2021-12-31 $426k 21k 20.35
2021-09-30 $314k 10k 30.36
2021-06-30 $172k 5.9k 29.14
2020-12-31 $22k 480 45.83
2020-09-30 $1.2M 29k 43.34
2020-06-30 $32k 600 53.33
2019-12-31 $101k 6.9k 14.56
2019-09-30 $21k 3.0k 7.07
2019-06-30 $43k 3.9k 11.07
2018-03-31 $6.3M 618k 10.24